Biological Indicator Testing

Comprehensive Biological Indicator Testing Services – D‑Value Determination, Sterility Assurance, and Regulatory Compliance for Sterilisation Processes

The rigorous testing of biological indicators (BIs) is an essential component of Sterility assurance, process validation, and routine monitoring for sterilisation processes across the pharmaceutical, medical device, healthcare, and food industries. Biological indicators – standardized preparations of highly resistant microorganisms (typically bacterial spores) on a carrier – provide a direct, quantitative measure of the lethality of a sterilisation process. They are indispensable for validating steam, ethylene oxide (EO), dry heat, hydrogen peroxide gas plasma, radiation, and other sterilisation cycles, as well as for routine process control. Regulatory bodies, including the US FDA, EU Annex 1, ISO 11138 series, and USP chapters, require that biological indicators be manufactured and tested according to rigorous, validated methods, and that their performance characteristics (e.g., D‑value, z‑value, population) be clearly documented. A poorly characterised BI can lead to false‑negative or false‑positive results, invalidated cycles, and ultimately, the release of non‑sterile products, with severe consequences for patient safety and regulatory compliance. Our ISO/IEC 17025‑accredited and GMP‑compliant laboratory offers a fully integrated biological indicator testing platform, covering the entire spectrum from D‑value determination and survivor curve analysis to population enumeration, Sterility testing, and resistance assessment under a wide range of sterilisation conditions. We deliver quantitative, traceable data, with full method validation, strict quality control, and expert interpretation, enabling you to validate your sterilisation processes, meet regulatory requirements, and ensure the highest level of Sterility assurance.

1. The Scientific and Regulatory Rationale for Biological Indicator Testing

Biological indicator testing serves multiple critical purposes: (a) to determine the resistance characteristics (D‑value, z‑value, survivor curve) of the BI for a defined sterilisation process; (b) to verify the population (spore count) of the BI to ensure it meets the specified requirements; (c) to confirm the identity and purity of the indicator organism; (d) to validate the sterilisation cycle by using BIs as an in‑process challenge; (e) to monitor the routine performance of sterilisation equipment; and (f) to support regulatory submissions and inspections. The choice of the test organism – typically Geobacillus stearothermophilus for steam and hydrogen peroxide, Bacillus atrophaeus for ethylene oxide and dry heat, or Bacillus pumilus for radiation – and the specific test conditions (temperature, pressure, sterilant concentration) must be tailored to the intended sterilisation process and the regulatory requirements. A poorly designed or executed test can lead to inaccurate D‑values, inappropriate cycle parameters, and non‑compliance with ISO 11138 or USP. Our service begins with a comprehensive consultation to define the optimal testing strategy for your BI type and sterilisation process, ensuring both scientific rigor and regulatory compliance.

2. Our Comprehensive Biological Indicator Testing Platform – D‑Value, Population, and Identity

We maintain a complete suite of validated BI testing methods, all performed in a dedicated microbiology and resistance‑testing facility with stringent quality controls, and using certified reference cultures (e.g., ATCC, NCTC) and, where appropriate, secondary reference BIs. Our portfolio includes:

2.1 D‑Value Determination – The Gold Standard for Resistance Characterisation
We determine the D‑value (decimal reduction time) – the time required to reduce a spore population by 90% (1 log) at a given sterilisation condition – using the survivor curve method or the fractional negative method (Spearman‑Karber). We perform these tests under precisely controlled conditions (temperature, pressure, and humidity) using validated equipment and procedures. We provide a full survivor curve with the calculated D‑value, the correlation coefficient (R²), and the 95% confidence interval. The D‑value is reported in minutes (or other relevant units) at the specified sterilisation condition.

2.2 Population (Spore Count) Enumeration – Quantitative Assessment of the BI
We perform spore population enumeration using a validated plate count method (pour‑plate, spread‑plate, or most‑probable‑number, MPN) to determine the total viable spore count per carrier or per unit of the BI. We use appropriate recovery media and incubation conditions, and we include a heat‑shock step to activate the spores. We provide the population count (CFU per carrier or per mL) with the relevant statistical uncertainty (expanded uncertainty at k=2). This is essential for ensuring that the BI meets the specified population (e.g., 10⁵ or 10⁶ CFU) and for validating the D‑value determination.

2.3 Resistance Assessment – Survivor Curve, z‑Value, and Fractional Negative Testing
In addition to the D‑value, we determine the z‑value – the temperature change required to alter the D‑value by a factor of 10 – by performing D‑value determinations at multiple temperatures. This is essential for understanding the temperature dependence of the BI's resistance and for validating sterilisation cycles that experience temperature variations. We also perform fractional negative tests (using a defined sample size) to estimate the D‑value when the survivor curve is not linear.

2.4 Identity and Purity Confirmation – Molecular and Phenotypic Characterisation
We confirm the identity and purity of the BI organism using a combination of: (a) morphological and biochemical tests (colony morphology, Gram stain, spore staining, and specific biochemical reactions); (b) MALDI‑TOF MS for rapid and accurate species‑level identification; and (c) 16S rRNA gene sequencing for definitive identification, if required. We provide a clear statement of the species and the strain, confirming that the BI is the intended organism and that it is free from contamination.

2.5 Sterility Testing of BIs – Verification of the Indicator’s Sterility
For BIs that are intended to be used as Sterility‑testing controls, we perform Sterility testing on a representative sample to confirm that the BI is not contaminated with extraneous microorganisms. We follow the USP <71> or EP 2.6.1 procedures, using appropriate media and incubation conditions. We provide a statement of Sterility (or the specific contaminant found, if any).

2.6 Resistance to Different Sterilisation Agents – Steam, EO, Dry Heat, VHP, and Radiation
We are equipped to test BIs against a wide range of sterilisation agents, including steam (saturated and superheated), ethylene oxide (EO), dry heat, hydrogen peroxide vapour (VHP), chlorine dioxide, ozone, and ionising radiation (gamma, electron beam). We use the specific carrier material and packaging (e.g., paper, glass, plastic) provided by the client, or we can use standardised BIs supplied by the manufacturer, to determine the D‑value and other resistance parameters under the relevant conditions. We provide a comprehensive report of the BI’s performance under your specific sterilisation cycle parameters.

2.7 Customised BI Testing – Non‑Standard Organisms and Conditions
For clients requiring testing against non‑standard organisms (e.g., environmental isolates, specific clinical strains) or non‑standard sterilisation conditions (e.g., unusual temperature, pressure, or gas composition), we develop and validate custom BI test protocols. We work with you to define the test parameters, the sample size, and the acceptance criteria, and we provide a full validation report.

3. Advanced Capabilities – Accelerated Ageing, Shelf‑Life Studies, and Sub‑Lethal Resistance

For clients requiring a deeper understanding of the BI’s performance over time or under challenging conditions, we offer a suite of customised, research‑grade services that go beyond routine D‑value and population determination:

3.1 Accelerated Ageing and Stability Studies – Shelf‑Life of the BI
We perform accelerated ageing studies to assess the stability and resistance of the BI over its intended shelf‑life. We store the BIs at elevated temperatures and/or humidities and periodically re‑determine the population, the D‑value, and, if required, the identity of the organism. We provide a shelf‑life prediction based on the Arrhenius model or other validated approaches, ensuring that the BI remains effective throughout its labelled shelf‑life.

3.2 Sub‑Lethal Injury and Recovery Studies – Assessing BI Performance after Sub‑Optimal Exposure
We can assess the sub‑lethal injury and recovery of spores after exposure to a sub‑lethal sterilisation treatment, by comparing the count on non‑selective and selective media. This is important for understanding the potential for the BI to give a false‑negative result when it is used in a cycle that is not perfectly lethal. We provide a detailed report of the injury recovery kinetics.

3.3 BI Performance in Complex Packaging and Load Configurations
We can test BIs under simulated real‑world load configurations (e.g., within product packaging, in different positions within a sterilisation chamber) to assess the impact of the load on the BI’s resistance. This is essential for validating the worst‑case conditions in the sterilisation cycle.

3.4 Method Validation and Regulatory Submission Support
We provide full method validation for your BI testing protocol, including the demonstration of: (a) specificity (identity confirmation); (b) linearity (for D‑value determination); (c) accuracy (by comparison with reference BIs); (d) precision (intra‑assay and inter‑assay); and (e) robustness to variations in the test parameters. The validation report is structured to meet the requirements of the FDA, EMA, and other regulatory authorities.

3.5 Data Review and Regulatory Submission Support
Our team of experienced microbiologists and regulatory specialists can assist you in the interpretation of the results, in the preparation of the required documentation for regulatory submissions (e.g., for process validation or for a BI‑manufacturer’s dossier), and in responding to queries from authorities. We provide a full data package, including the raw data, the statistical analysis, and the uncertainty budgets.

4. Data Integrity, Standardisation, and Comprehensive Reporting

All analyses are conducted under a strict quality management system that includes the use of certified reference cultures, routine positive and negative controls, and participation in proficiency testing schemes (where available). Our reports provide:

• Full method description – detailing the test organism, the carrier material, the sterilisation conditions, the media used, and the data analysis method.
• Detailed results – including the D‑value (with confidence interval), the z‑value (if determined), the population count (with uncertainty), the identity confirmation, and the Sterility test results.
• Quality control data – the results of the concurrent controls, confirming the validity of the test run.
• Graphical outputs – including survivor curves, semi‑log plots, and, where applicable, growth curves.
• Interpretative comments – by our senior microbiologists, providing an assessment of the BI’s performance, its suitability for the intended sterilisation process, and any recommendations for its use.

Our reports are structured to meet the requirements of regulatory audits, customer inspections, and internal quality assurance.

Turnaround times: 2‑3 weeks for D‑value determination and population counts, 3‑4 weeks for z‑value determination and accelerated ageing studies, and 1‑2 weeks for identity confirmation and Sterility testing. Express services are available for urgent projects.

5. Why Choose Our Laboratory for Biological Indicator Testing

We are one of the few laboratories that hold ISO/IEC 17025 accreditation and GMP compliance for the full spectrum of BI testing methods, including D‑value, population, and z‑value determination, for all major sterilisation agents. Our integrated infrastructure combines state‑of‑the‑art resistance‑testing equipment, automated counting systems, and a fully validated microbiology facility – enabling cross‑verification of results and a comprehensive characterisation of your BI. Our team comprises PhD‑level microbiologists and validation specialists with extensive experience in sterilisation science, method development, and regulatory submissions, and we have a proven track record of supporting pharmaceutical, medical device, and healthcare companies in their Sterility assurance programmes.

We offer unparalleled flexibility: we accept all types of BIs – from self‑contained and strip BIs to custom‑prepared BIs on specific carriers – and we provide customised test protocols to meet your specific cycle parameters and regulatory requirements. Our secure online portal enables real‑time tracking, access to raw data, and downloadable certificates of analysis.

Our modular pricing ensures cost‑effectiveness: you select the level of analysis – from a simple D‑value determination to a full validation package – with discounts for routine monitoring programmes and bulk submissions. We also provide training, method transfer, and technical consultancy to help you build or strengthen your internal BI testing capabilities.

With a proven history of serving over 80 clients in the pharmaceutical, medical device, and healthcare sectors, we have enabled our partners to validate their sterilisation processes, ensure patient safety, and achieve regulatory compliance. We invite you to leverage our expertise for your biological indicator testing needs.

Contact our technical experts today to discuss your BI type, sterilisation process, and specific requirements. We will design a tailored testing plan and provide a detailed proposal within one business day.